ArticleNature communications2026

Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes.

Kuang-Ming Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.